Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 5Genitourinary 3Breast 3Thoracic 2Sarcoma 2Head & Neck 2Gastrointestinal 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Lymphoma 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Follicular 11Leukemia 11Lymphoma, Large B-Cell, Diffuse 10Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Mantle-Cell 6Leukemia, Myeloid, Acute 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Hodgkin Disease 5Congenital Abnormalities 5Burkitt Lymphoma 5Waldenstrom Macroglobulinemia 4Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Lymphoma, Non-Hodgkin 4Immunoblastic Lymphadenopathy 4Myelodysplastic Syndromes 3Lymphoma, T-Cell, Peripheral 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Extranodal NK-T-Cell 3Leukemia, Myeloid, Accelerated Phase 3Multiple Myeloma 2Graft vs Host Disease 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Blast Crisis 2

Interventions

Therapeutics 6Flow Cytometry 5Cyclophosphamide 4Polymerase Chain Reaction 3Methylprednisolone 3Immunoenzyme Techniques 3sargramostim 2liposomal amphotericin B 2aflibercept 2Radiotherapy 2Psychiatric Rehabilitation 2Prednisone 2Peripheral Blood Stem Cell Transplantation 2Paclitaxel 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Filgrastim 2Dexamethasone 2Caspofungin 2Calcium Dobesilate 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2Amifostine 2Alemtuzumab 2thymoglobulin 1tanespimycin 1liposomal doxorubicin 1entinostat 1dexamethasone acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Gene Expression Profiling × Lymphoid × Clear all
NCT00904514 2018-10-05

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

National Institutes of Health Clinical Center (CC)

Terminated
241 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Brenner Tumor, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sezary Syndrome, Stomach Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡